Back
Nxera Pharma 10K Form
Sell
27
SOLTF
Nxera Pharma
Last Price:
$5.91
Seasonality Move:
15.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SOLTF News And Ratings
See the #1 stock for the next 7 days that we like better than SOLTF
SOLTF Financial Statistics
Sales & Book Value
| Annual Sales: | $190.6M |
|---|---|
| Cash Flow: | $-14.8M |
| Price / Cash Flow: | 57.47 |
| Annual Sales: | $4.99 |
| Price / Book: | 1.19 |
Profitability
| EPS (TTM): | -0.41870 |
|---|---|
| Net Income (TTM): | $-37.6M |
| Gross Margin: | $140.3M |
| Return on Equity: | -8.65% |
| Return on Assets: | -3.71% |
Nxera Pharma Earnings Forecast
Key Nxera Pharma Financial Ratios
-
The Gross Profit Margin over the past 20 years for SOLTF is 73.59%.
-
The Selling, General & Administrative Expenses for SOLTF have been equal to 55.54% of Gross Profit Margin.
-
The Research & Development expenses have been 40.98% of Revenue.
-
The Net Earning history of SOLTF is -16.78% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 8 years.
Nxera Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SOLTF |
| Website: | sosei.com |
Debt
| Debt-to-Equity Ratio: | 0.93 |
|---|---|
| Current Ratio: | 3.72 |
| Quick Ratio: | 2.83 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SOLTF Technical Analysis vs Fundamental Analysis
Sell
27
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy or a Sell?
-
Nxera Pharma stock is rated a SellThe current Nxera Pharma [SOLTF] share price is $5.91. The Score for SOLTF is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.